Kathrin Schumann
Impact in
- Oncology top 2%
- CAR-T cell therapy research
Papers in
-
- CRISPR and Genetic Engineering 10
- Oncology 9
- CAR-T cell therapy research 7
- Co-authors
- Alexander Marson (7 shared papers)Rachel E. Gate (2 shared papers)Chun Ye (2 shared papers)Wendell A. Lim (2 shared papers)Levi J. Rupp (2 shared papers)Kole T. Roybal (2 shared papers)Jennifer A. Doudna (3 shared papers)Meena Subramaniam (1 shared paper)
- Journals
- Cell Reports Medicine (2 papers)The Journal of Immunology (2 papers)Cell Reports (1 paper)Theriogenology (1 paper)Journal of Neuroinflammation (1 paper)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Kathrin Schumann
21 papers receiving 2.2k citations
Kathrin Schumann's Hit Papers
Peers
Comparison fields: 5 of 100
- Business and International Management 104
- Oncology 937
- Virology 144
- Immunology 568
- Aging 36
Countries citing papers authored by Kathrin Schumann
This map shows the geographic impact of Kathrin Schumann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathrin Schumann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathrin Schumann more than expected).
Fields of papers citing papers by Kathrin Schumann
This network shows the impact of papers produced by Kathrin Schumann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathrin Schumann. The network helps show where Kathrin Schumann may publish in the future.
Co-authors
The 25 scholars most cited alongside Kathrin Schumann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells Hit paper breakdown → | 2017 | 592 |
| 2 | Generation of knock-in primary human T cells using Cas9 ribonucleoproteins Hit paper breakdown → | 2015 | 540 |
| 3 | 2016 | 241 | |
| 4 | 2009 | 214 | |
| 5 | 2016 | 131 | |
| 6 | 2019 | 120 | |
| 7 | 2011 | 92 | |
| 8 | 2018 | 80 | |
| 9 | 2011 | 56 | |
| 10 | 2021 | 37 | |
| 11 | 2016 | 20 | |
| 12 | 2023 | 15 | |
| 13 | 2014 | 15 | |
| 14 | 2016 | 13 | |
| 15 | 2022 | 12 | |
| 16 | 2014 | 11 | |
| 17 | 2022 | 9 | |
| 18 | 2014 | 5 | |
| 19 | 2024 | 2 | |
| 20 | PCR amplification of the phaseolin-genes in 18 species of the genus Phaseolus. | 1995 | 1 |
About Kathrin Schumann
Kathrin Schumann is a scholar working on Molecular Biology, Oncology, Immunology, Virology and Animal Science and Zoology, having authored 22 papers that have together received 2.2k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (10 papers), CAR-T cell therapy research (7 papers), Immune Cell Function and Interaction (5 papers), T-cell and B-cell Immunology (4 papers), HIV Research and Treatment (3 papers), Nanowire Synthesis and Applications (2 papers), Immunotherapy and Immune Responses (2 papers) and Rabbits: Nutrition, Reproduction, Health (2 papers). The work is most often cited by research in Business and International Management (104 citations), Oncology (937 citations), Virology (144 citations), Immunology (568 citations) and Aging (36 citations). Kathrin Schumann has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Alexander Marson, Rachel E. Gate, Chun Ye, Wendell A. Lim, Levi J. Rupp, Kole T. Roybal, Jennifer A. Doudna, Meena Subramaniam, Jeffrey A. Bluestone and Dimitre R. Simeonov. Their work appears in journals such as Cell Reports Medicine, The Journal of Immunology, Cell Reports, Theriogenology and Journal of Neuroinflammation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.